<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>8. The Complement system</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="immunology-07a-antibodies.html" class="nav-button"> 
                        <span class="nav-icon"></span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 20.51%;"></div> <!-- (8/39)*100 -->
                        </div>
                       <span class="progress-text">Lecture 8 of 39</span> 
                    </div>
                    <a href="immunology-09a-mhc-ppt.html" class="nav-button"> 
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon"></span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">THE COMPLEMENT SYSTEM</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: section-complement-intro -->
                <section id="section-complement-intro" class="content-section" aria-labelledby="section-heading-complement-intro">
                    <h2 id="section-heading-complement-intro" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Introduction to the Complement System</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>The complement system is a defensive system consisting of over 30 proteins produced by the liver and found circulating in blood serum and within tissues throughout the body.</li>
                            <li>Antibodies are not directly toxic or destructive to pathogens, but facilitate host defense through
                                <ul>
                                    <li>Neutralizing pathogens - preventing them or toxins they produce from binding to host cells</li>
                                    <li>Opsonization - phagocytosis</li>
                                    <li>Complement activation.</li>
                                </ul>
                            </li>
                            <li>Together, proteins of the complement system destroy microbes by :
                                <ol>
                                    <li>Cytolysis</li>
                                    <li>Inflammation</li>
                                    <li>Phagocytosis</li>
                                </ol>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-complement-intro -->

                <!-- START: section-complement-functions -->
                <section id="section-complement-functions" class="content-section" aria-labelledby="section-heading-complement-functions">
                    <h2 id="section-heading-complement-functions" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Therefore, complement system:</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Is one of two major humoral arms of innate immunity</li>
                            <li>Acts in concert with adaptive humoral immunity (antibodies) and innate cellular immunity</li>
                            <li>Is a cascade of serine protease pro-enzymes and their substrates.</li>
                            <li>Functions
                                <ul>
                                    <li>Inflammation</li>
                                    <li>Opsonization (enhance phagocytosis)</li>
                                    <li>Lytic activity</li>
                                    <li>Antigen-antibody (immune) complex clearance</li>
                                    <li>Enhance/modulate antibody production by B cells.</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-complement-functions -->

                <!-- START: section-complement-naming -->
                <section id="section-complement-naming" class="content-section" aria-labelledby="section-heading-complement-naming">
                    <h2 id="section-heading-complement-naming" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Naming of complement proteins:</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Complement proteins are usually designated by an uppercase letter C and are inactive until they are split into fragments (products).</li>
                            <li>The proteins are numbered C1 through C9, named for the order in which they were discovered.</li>
                            <li>The fragments are activated proteins and are indicated by the lowercase letters a and b.
                                <ul>
                                    <li>For example, inactive complement protein C3 is split into two activated fragments, C3a and C3b.</li>
                                </ul>
                            </li>
                            <li>The activated fragments carry out the destructive actions of the C1 through C9 complement proteins.</li>
                            <li>Complement proteins act in a cascade, that is, one reaction triggers another, which in turn triggers another, and so on.</li>
                            <li>Also, as part of the cascade, more product is formed with each succeeding reaction so that the effect is amplified many times as the reactions continue.</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-06-1.jpg" alt="Overview diagram of the complement system activation pathways (Classical, Alternative, Lectin) leading to C3 activation and subsequent effector functions: opsonization, inflammation, and cytolysis (MAC formation)." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-complement-naming -->

                <!-- START: section-outcomes-activation -->
                <section id="section-outcomes-activation" class="content-section" aria-labelledby="section-heading-outcomes-activation">
                    <h2 id="section-heading-outcomes-activation" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">THE OUTCOMES OF COMPLEMENT ACTIVATION</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>When C3 is activated, it splits into C3a and C3b. C3b binds to the surface of a microbe and receptors on phagocytes attach to the C3b.</li>
                            <li>Thus C3b enhances phagocytosis by coating a microbe, a process called <dfn>opsonization</dfn>, or immune adherence.</li>
                            <li>Opsonization promotes attachment of a phagocyte to a microbe.</li>
                            <li>C3b also initiates a series of reactions that result in cytolysis.
                                <ul>
                                    <li>First, C3b splits C5. Fragment C5b then binds to C6 and C7, which attach to the invading cell plasma membrane.</li>
                                    <li>Next, C8 and several C9 molecules join the other complement proteins and together form a cylinder-shaped <dfn>Membrane Attacking Complex (MAC)</dfn>, which inserts into the membrane.</li>
                                    <li>The MAC creates transmembrane channels (holes) in the membrane that result in <dfn>cytolysis</dfn>, the bursting of the microbial cell due to the inflow of extracellular fluid through the channels.</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-outcomes-activation -->

                <!-- START: section-c3a-c5a-roles -->
                <section id="section-c3a-c5a-roles" class="content-section" aria-labelledby="section-heading-c3a-c5a-roles">
                    <h2 id="section-heading-c3a-c5a-roles" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">On the other hand:</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>C3a and C5a bind to mast cells and cause them to release histamine and other chemicals that increase blood vessel permeability during inflammation.</li>
                            <li>C5a also functions as a very powerful chemotactic factor that attracts phagocytes to the site of an infection.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-c3a-c5a-roles -->

                <!-- START: section-inflammation-stimulated -->
                <section id="section-inflammation-stimulated" class="content-section" aria-labelledby="section-heading-inflammation-stimulated">
                    <h2 id="section-heading-inflammation-stimulated" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">INFLAMMATION STIMULATED BY COMPLEMENT SYSTEM</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-10-1.jpg" alt="Diagram showing how complement fragments C3a and C5a contribute to inflammation by causing histamine release from mast cells, leading to increased blood vessel permeability and attraction of phagocytes." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-inflammation-stimulated -->

                <!-- START: section-pathways-activation -->
                <section id="section-pathways-activation" class="content-section" aria-labelledby="section-heading-pathways-activation">
                    <h2 id="section-heading-pathways-activation" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">PATHWAYS FOR COMPLEMENT ACTIVATION:</span>
                    </h2>
                    <div class="content-card">
                        <ol>
                            <li>The Classical pathway</li>
                            <li>The Alternative pathway</li>
                            <li>The Lectin pathway</li>
                        </ol>
                    </div>
                </section>
                <!-- END: section-pathways-activation -->

                <!-- START: section-classical-pathway -->
                <section id="section-classical-pathway" class="content-section" aria-labelledby="section-heading-classical-pathway">
                    <h2 id="section-heading-classical-pathway" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">A) THE CLASSICAL PATHWAY.</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>The classical pathway, so named because it was the first to be discovered, is initiated when antibodies bind to antigens (microbes) and occurs as follows:
                                <ul>
                                    <li>Antibodies attach to antigens, forming antigenantibody complexes.</li>
                                    <li>Example of antigens: proteins or large polysaccharides on the surface of a bacterium or other cell.</li>
                                    <li>The antigen-antibody complexes bind and activate C1.</li>
                                    <li>Next, activated C1 activates C2 and C4 by splitting them.</li>
                                    <li>C2 is split into fragments called C2a and C2b. and C4 is split into fragment, called C4a and C4b.</li>
                                    <li>C2a and C4b combine and together they activate C3 by splitting it into C3a and C3b.</li>
                                    <li>The C3 fragments then initiate cytolysis, inflammation, and opsonization.</li>
                                </ul>
                            </li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-14-1.jpg" alt="Diagram detailing the steps of the Classical Pathway of complement activation, starting with antigen-antibody complex formation and C1 activation, leading to C3 cleavage." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-classical-pathway -->

                <!-- START: section-alternative-pathway -->
                <section id="section-alternative-pathway" class="content-section" aria-labelledby="section-heading-alternative-pathway">
                    <h2 id="section-heading-alternative-pathway" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">B) THE ALTERNATIVE PATHWAY.</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>The alternative pathway is so named because it was discovered after the classical pathway.</li>
                            <li>Unlike the classical pathway, the alternative pathway does not involve antibodies.</li>
                            <li>The alternative pathway is activated by contact between certain complement proteins and a pathogen.
                                <ul>
                                    <li>C3 is constantly present in the blood.</li>
                                    <li>It combines with complement proteins called factor B, factor D, and factor P (properdin) on the surface of a pathogen.</li>
                                    <li>The complement proteins are attracted to microbial cell surface material (mostly lipid-carbohydrate complexes of certain bacteria and fungi).</li>
                                    <li>Once the complement proteins combine and interact, C3 is split into fragments C3a and C3b.</li>
                                    <li>As in the classical pathway, C3a participates in inflammation, and C3b functions in cytolysis and opsonization.</li>
                                </ul>
                            </li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-17-1.jpg" alt="Diagram detailing the steps of the Alternative Pathway of complement activation, initiated by C3b binding to pathogen surface and interaction with Factors B, D, and P, leading to further C3 cleavage." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-alternative-pathway -->

                <!-- START: section-lectin-pathway -->
                <section id="section-lectin-pathway" class="content-section" aria-labelledby="section-heading-lectin-pathway">
                    <h2 id="section-heading-lectin-pathway" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">C) THE LECTIN PATHWAY.</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>The lectin pathway is the most recently discovered mechanism for complement activation.</li>
                            <li>When macrophages ingest bacteria, viruses, and other foreign matter by phagocytosis, they release chemicals that stimulate the liver to produce lectins, proteins that bind to carbohydrates.
                                <ul>
                                    <li>One such lectin, mannose-binding lectin (MBL), binds to the carbohydrate mannose.</li>
                                    <li>MBL binds to many pathogens because the MBL molecules recognize a distinctive pattern of carbohydrates that includes mannose, which is found in bacterial cell walls and on some viruses.</li>
                                    <li>As a result of binding, MBL functions as an opsonin to enhance phagocytosis and activates C2 and C4.</li>
                                    <li>C2a and C4b activate C3.</li>
                                </ul>
                            </li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-20-1.jpg" alt="Diagram detailing the steps of the Lectin Pathway of complement activation, initiated by Mannose-Binding Lectin (MBL) binding to pathogen carbohydrates, leading to C2 and C4 activation, and subsequent C3 cleavage." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-lectin-pathway -->

                <!-- START: section-three-points-entry -->
                <section id="section-three-points-entry" class="content-section" aria-labelledby="section-heading-three-points-entry">
                    <h2 id="section-heading-three-points-entry" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Three Points of Entry into the Complement Cascade</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-21-1.jpg" alt="Summary diagram illustrating the three pathways (Classical, Lectin, Alternative) converging at the activation of C3, which then leads to the common terminal pathway for MAC formation and effector functions." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-three-points-entry -->

                <!-- START: section-overview-cascade -->
                <section id="section-overview-cascade" class="content-section" aria-labelledby="section-heading-overview-cascade">
                    <h2 id="section-heading-overview-cascade" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Overview of Complement Cascade</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-22-1.jpg" alt="Initial part of a multi-slide overview of the complement cascade, showing the start of the classical pathway with C1q,r,s." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-23-1.jpg" alt="Continuation of the complement cascade overview, showing C4 and C2 cleavage and formation of C3 convertase (C4b2a)." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-24-1.jpg" alt="Further continuation of the complement cascade, detailing C3 cleavage, C5 convertase formation, and the assembly of the Membrane Attack Complex (MAC)." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-overview-cascade -->

                <!-- START: section-arcane-nomenclature -->
                <section id="section-arcane-nomenclature" class="content-section" aria-labelledby="section-heading-arcane-nomenclature">
                    <h2 id="section-heading-arcane-nomenclature" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Arcane Nomenclature</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Classical pathway components and components shared by all pathways - C followed by number; fragments denoted by lower case letter
                                <ul>
                                    <li>Examples
                                        <ul>
                                            <li>C4 - C4 protein</li>
                                            <li>C4a - smaller soluble fragment</li>
                                            <li>C4b - larger fragment binds to surface (of microbe)</li>
                                        </ul>
                                    </li>
                                    <li>There is one exception - for C2, C2b = smaller soluble fragment, C2a = larger fragment that binds to surface of microbe</li>
                                </ul>
                            </li>
                            <li>Alternative Pathway Proteins - Upper case letter, fragments denoted by lower case letter
                                <ul>
                                    <li>Example
                                        <ul>
                                            <li>B $\rightarrow$ Bb</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-arcane-nomenclature -->

                <!-- START: section-c3-convertase-types -->
                <section id="section-c3-convertase-types" class="content-section" aria-labelledby="section-heading-c3-convertase-types">
                    <h2 id="section-heading-c3-convertase-types" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Two Types of C3 Convertase</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-26-1.jpg" alt="Diagram comparing the C3 convertases of the classical/lectin pathway (C4b2a) and the alternative pathway (C3bBb)." class="content-image">
                        </figure>
                        <p>C3b bound to the microbial surface can also bind factor B $\rightarrow$ C3bBb; in other words, the alternative pathway can amplify complement activation by the classical pathway.</p>
                    </div>
                </section>
                <!-- END: section-c3-convertase-types -->

                <!-- START: section-c3-c5-convertases -->
                <section id="section-c3-c5-convertases" class="content-section" aria-labelledby="section-heading-c3-c5-convertases">
                    <h2 id="section-heading-c3-c5-convertases" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">C3 and C5 convertases</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-27-1.jpg" alt="Diagram showing the formation of C3 convertase in the classical pathway." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-28-1.jpg" alt="Diagram expanding on C3 and C5 convertase formation and action, leading to C5 cleavage and initiation of MAC formation." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-c3-c5-convertases -->

                <!-- START: section-pathways-converge -->
                <section id="section-pathways-converge" class="content-section" aria-labelledby="section-heading-pathways-converge">
                    <h2 id="section-heading-pathways-converge" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Divergent Pathways Converge for Effector Function</span>
                    </h2>
                    <div class="content-card">
                        <p>Classical Pathway</p>
                        <p>Alternative Pathway</p>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-29-1.jpg" alt="Diagram illustrating how the classical and alternative pathways converge at C3 activation, leading to common effector functions like inflammation, opsonization, and lysis via MAC." class="content-image">
                        </figure>
                        <p>Classical Pathway</p>
                        <p>Alternative Pathway</p>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-30-1.jpg" alt="Similar to previous, reinforcing the convergence of complement pathways and their effector outcomes." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: section-pathways-converge -->

                <!-- START: section-terminal-pathway-mac -->
                <section id="section-terminal-pathway-mac" class="content-section" aria-labelledby="section-heading-terminal-pathway-mac">
                    <h2 id="section-heading-terminal-pathway-mac" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">The Terminal Pathway Generates a Membrane Attack Complex to Lyse Pathogens</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-31-1.jpg" alt="Diagram showing the assembly of the Membrane Attack Complex (MAC) from C5b, C6, C7, C8, and multiple C9 molecules, forming a pore in the pathogen membrane." class="content-image">
                        </figure>
                        <p>Pore inserts through lipid layer of membrane - lytic for Gramnegative bacteria and mammalian cells not Gram-positives</p>
                    </div>
                </section>
                <!-- END: section-terminal-pathway-mac -->

                <!-- START: section-complement-lysis -->
                <section id="section-complement-lysis" class="content-section" aria-labelledby="section-heading-complement-lysis">
                    <h2 id="section-heading-complement-lysis" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Complement Lysis</span>
                    </h2>
                    <div class="content-card">
                        <p><em>(This section likely referred to a visual not captured as an image link, or was a conceptual heading for the MAC's action.)</em></p>
                    </div>
                </section>
                <!-- END: section-complement-lysis -->

                <!-- START: section-complement-ward -->
                <section id="section-complement-ward" class="content-section" aria-labelledby="section-heading-complement-ward">
                    <h2 id="section-heading-complement-ward" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Complement Ward (Regulation)</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>There are inhibitors of complement that prevent it from leading to self-destruction.</li>
                            <li>These include the C1-inhibitor, the ability to destroy C3 and C5 convertases, and the inhibition of MAC.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-complement-ward -->

                <!-- START: section-c1-inhibition -->
                <section id="section-c1-inhibition" class="content-section" aria-labelledby="section-heading-c1-inhibition">
                    <h2 id="section-heading-c1-inhibition" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">C1-Inhibition</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>C1-inhibitor binds to C1 and holds it inactive; if it does become active, C1inhibitor serves as a suicide substrate</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-c1-inhibition -->

                <!-- START: section-regulatory-proteins -->
                <section id="section-regulatory-proteins" class="content-section" aria-labelledby="section-heading-regulatory-proteins">
                    <h2 id="section-heading-regulatory-proteins" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Regulatory Proteins Prevent Self Injury by the Complement System at Multiple Steps</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">C1 Inhibition - C1INH</h3>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-35-1.jpg" alt="Diagram illustrating C1 inhibitor (C1INH) binding to C1r and C1s to prevent activation of the classical pathway." class="content-image">
                            <figcaption>Figure 7-47 The Immune System, 2/e (© Garland Science 2005)</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Block MAC Assembly - CD59</h3>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-35-2.jpg" alt="Diagram showing CD59 (protectin) on host cells inhibiting the formation of the Membrane Attack Complex by preventing C9 polymerization." class="content-image">
                            <figcaption>Figure 7-51 The Immune System, 2/e (© Garland Science 2005)</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Cleave and Inactivate C3b - Factors H and I</h3>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-35-3.jpg" alt="Diagram showing Factor H binding to C3b on a host cell surface, facilitating cleavage of C3b by Factor I into iC3b, thus inactivating it." class="content-image">
                            <figcaption>Inactivation of C3b by factor H and factor I to give fragment iC3b on microbial surface (though typically protects host cells).</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Dissociate C3 Convertase - DAF, MCP and Factor I</h3>
                        <figure>
                            <img src="../assets/images/2025_06_15_c51b29e57720ff8bc096g-35-4.jpg" alt="Diagram showing Decay-Accelerating Factor (DAF) and Membrane Cofactor Protein (MCP) on host cells dissociating C3 convertases (C4b2a and C3bBb) and facilitating Factor I mediated cleavage of C3b/C4b." class="content-image">
                            <figcaption>Figure 7-50 The Immune System, 2/e (© Garland Science 2005)</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: section-regulatory-proteins -->

                <!-- START: section-convertase-destruction -->
                <section id="section-convertase-destruction" class="content-section" aria-labelledby="section-heading-convertase-destruction">
                    <h2 id="section-heading-convertase-destruction" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Convertase destruction</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Many things can inactivate the C3 convertase, including decay accelerating factor (DAF) on endothelial and blood cells, and CR1 on immune cells. Also, Factor I can proteolyze C4b when C4b is complexed with the membrane cofactor protein (MCP). Similarly, Factor H, DAF, and CR1 can inhibit C3bBbP, ultimately recruiting Factor I.</li>
                            <li>All of the fragments released by dissociation or cleavage still encourage immunologically competent cells to proliferate or invade the area.</li>
                            <li>Thus, soluble fragments are chemotactic while bound fragments are opsonic (and/or biochemically active).</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-convertase-destruction -->

                <!-- START: section-mac-inhibition -->
                <section id="section-mac-inhibition" class="content-section" aria-labelledby="section-heading-mac-inhibition">
                    <h2 id="section-heading-mac-inhibition" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">MAC inhibition</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Protectin (CD59), in the membrane, binds to C8 and C9, blocking the growth of the MAC. Vitronectin, in the serum, acts similarly.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-mac-inhibition -->

                <!-- START: section-evolution -->
                <section id="section-evolution" class="content-section" aria-labelledby="section-heading-evolution">
                    <h2 id="section-heading-evolution" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Evolution</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Many of the complement proteins are structurally related, consisting of varying numbers of short consensus repeats (SCRs). Unfortunately, bacteria and parasites can take advantage of the complement inhibitors or even complement receptors.</li>
                        </ul>
                        <h3 class="subsection-heading">Innate-Adaptive Interplay</h3>
                        <ul>
                            <li>B-cells have complement receptors (CR2 in association with CD19) in addition to surface Ig's.</li>
                            <li>Cross-linking of CD19 and sIgM in B-cells leads to a 100x-increase in the activation sensitivity of the cells.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-evolution -->

                <!-- START: section-complement-deficiency-states -->
                <section id="section-complement-deficiency-states" class="content-section" aria-labelledby="section-heading-complement-deficiency-states">
                    <h2 id="section-heading-complement-deficiency-states" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Complement Deficiency States</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Increased risk for infection with capsulated bacterial pathogens
                                <ul>
                                    <li>early classical pathway components (C1, C4 and C2) and C3 - Streptococcus pneumoniae - Gram-positive bacterium</li>
                                    <li>early classical pathway components, C3, and alternative pathway and terminal components - Neisseria meningitidis -Gram-negative bacterium</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-complement-deficiency-states -->

                <!-- START: section-summary -->
                <section id="section-summary" class="content-section" aria-labelledby="section-heading-summary">
                    <h2 id="section-heading-summary" class="section-heading">
                         <span class="heading-icon"></span>
                        <span class="heading-text">Summary: COMPLEMENT SYSTEM</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Complement bridges the innate and the adaptive immune systems.</li>
                            <li>It leads to chemotaxis.</li>
                            <li>It opsonizes pathogens.</li>
                            <li>It is a proteolytic cascade, much like blood clotting.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: section-summary -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="immunology-07a-antibodies.html" class="nav-button"> 
                        <span class="nav-icon"></span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 20.51%;"></div> 
                        </div>
                       <span class="progress-text">Lecture 8 of 39</span> 
                    </div>
                    <a href="immunology-09a-mhc-ppt.html" class="nav-button"> 
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon"></span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script> 
</body>
</html>